Vasiliy N. Smirnov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vasiliy N. Smirnov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr N. Gridin
Regional Clinical Hospital
2 shared publications - Grigoriy A. Gromyko
Yaroslavl State Medical University
2 shared publications - Il'YA N. Staroverov
Yaroslavl State Medical University
2 shared publications - Aleksandr N. Lishchuk
Vishnevsky Central Military Clinical Hospital
1 shared publication - Aleksandr V. Ivanov
Vishnevsky Scientific Medical Center for High Medical Technologies of the Ministry of Defence of the Russian Federation
1 shared publication I.N. Staroverov
Yaroslavl State Medical University
1 shared publication
Latest Publications
- 3 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 18 (6)
Paroxysmal atrial fibrillation in patients with sinoatrial blockade undergoing permanent pacing and metabolic therapy
Objective. To study the effect of trimetazidine dihydrochloride on the total number of atrial fibrillation paroxysms in patients with sinus node weakness syndrome and permanent two-chamber pacing. Material and methods. The study included 138 patients with various types of sinoatrial blockades and two-chamber pacing systems. Two groups of patients were formed: 1 — patients receiving metabolic therapy; 2 — patients not receiving metabolic therapy. The effect of trimetazidine dihydrochloride on the total number of atrial fibrillation paroxysms was evaluated in 3 and 12 months after implantation of two-chamber pacing system. All patients of both groups received standard therapy for concomitant diseases. Results. Trimetazidine dihydrochloride in patients with various types of sinoatrial blockades after implantation of two-chamber pacing system reduces the total number of paroxysms of atrial fibrillation. There was a significant (p<0.05) decrease in the number of paroxysms of atrial fibrillation under metabolic therapy in 3 and 12 months after pacing system implantation. Conclusion. Administration of trimethazidine dihydrochloride as a part of complex therapy reduces the total number of paroxysms of atrial fibrillation in patients with sinus node weakness syndrome after implantation of two-chamber pacing system.
- 3 December 2025
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 18 (6)
Paroxysmal atrial fibrillation in patients with sinoatrial blockade undergoing permanent pacing and metabolic therapy
Objective. To study the effect of trimetazidine dihydrochloride on the total number of atrial fibrillation paroxysms in patients with sinus node weakness syndrome and permanent two-chamber pacing. Material and methods. The study included 138 patients with various types of sinoatrial blockades and two-chamber pacing systems. Two groups of patients were formed: 1 — patients receiving metabolic therapy; 2 — patients not receiving metabolic therapy. The effect of trimetazidine dihydrochloride on the total number of atrial fibrillation paroxysms was evaluated in 3 and 12 months after implantation of two-chamber pacing system. All patients of both groups received standard therapy for concomitant diseases. Results. Trimetazidine dihydrochloride in patients with various types of sinoatrial blockades after implantation of two-chamber pacing system reduces the total number of paroxysms of atrial fibrillation. There was a significant (p<0.05) decrease in the number of paroxysms of atrial fibrillation under metabolic therapy in 3 and 12 months after pacing system implantation. Conclusion. Administration of trimethazidine dihydrochloride as a part of complex therapy reduces the total number of paroxysms of atrial fibrillation in patients with sinus node weakness syndrome after implantation of two-chamber pacing system.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
A Clinical Case of Vein of Marshall Alcohol Ablation for Treatment of Perimitral Flutter in a Patient with Several Unsuccessful Ablation Surgeries in History
INTRODUCTION: Catheter radiofrequency or cryoablation operations in accordance with the existing recommendations are one of the main methods of treatment for atrial fibrillation (AF). However, in some cases, pulmonary vein isolation is not sufficient to effectively control arrhythmia, and linear ablations are required in the left atrium during the operation. Despite increased effectiveness of such ablations to prevent AF recurrences, a significant problem in this group of patients is incisional atrial flutter. The critical zone for incisional left-atrial arrhythmias in the vast majority of patients is the mitral isthmus due to its anatomical and electrophysiological features. At the same time, mitral isthmus ablation is associated with technical difficulties due to thickness of the myocardium in this zone, complex anatomical structure of this region and a cooling effect of blood flow in the circumflex branch of the left coronary artery with the probability of reaching the conduction block in 40%–80% of cases. The operation of alcohol ablation of the mitral isthmus proposed by M. Valdebarano, et al. is an effective additional tool for treating the perimitral atrial flutter and achieving the conduction block in it. The clinical case presented by us shows the effective use of this operation in a patient after several cryo and radiofrequency ablation procedures AF for the treatment of perimitral atrial flutter refractory to other methods. CONCLUSION: Alcohol ablation of the vein of Marshall can be an effective tool for the treatment of perimitral atrial flutter in patients with several past cryo and radiofrequency ablations in the left atrium.
- 31 December 2024
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 12 (4)
A Clinical Case of Vein of Marshall Alcohol Ablation for Treatment of Perimitral Flutter in a Patient with Several Unsuccessful Ablation Surgeries in History
INTRODUCTION: Catheter radiofrequency or cryoablation operations in accordance with the existing recommendations are one of the main methods of treatment for atrial fibrillation (AF). However, in some cases, pulmonary vein isolation is not sufficient to effectively control arrhythmia, and linear ablations are required in the left atrium during the operation. Despite increased effectiveness of such ablations to prevent AF recurrences, a significant problem in this group of patients is incisional atrial flutter. The critical zone for incisional left-atrial arrhythmias in the vast majority of patients is the mitral isthmus due to its anatomical and electrophysiological features. At the same time, mitral isthmus ablation is associated with technical difficulties due to thickness of the myocardium in this zone, complex anatomical structure of this region and a cooling effect of blood flow in the circumflex branch of the left coronary artery with the probability of reaching the conduction block in 40%–80% of cases. The operation of alcohol ablation of the mitral isthmus proposed by M. Valdebarano, et al. is an effective additional tool for treating the perimitral atrial flutter and achieving the conduction block in it. The clinical case presented by us shows the effective use of this operation in a patient after several cryo and radiofrequency ablation procedures AF for the treatment of perimitral atrial flutter refractory to other methods. CONCLUSION: Alcohol ablation of the vein of Marshall can be an effective tool for the treatment of perimitral atrial flutter in patients with several past cryo and radiofrequency ablations in the left atrium.
- 7 October 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (3) , 305-312
Study of Electrophysiological Properties of Atrioventricular Node in Permanent Cardiac Pacing under Influence of Trimetazidine Dihydrochloride
INTRODUCTION: Dual-chamber cardiac pacing permits to maintain permanent atrial-ventricular synchronization. Physiological sequence of propagation of the impulse from atria to ventricles is provided with an artificial delay analogous to delay of propagation of excitation through the atrioventricular (AV) node of a heathy individual. The delay interval is formed so that to minimize stimulation of the right ventricle. This preserves the left ventricular ejection fraction, reduces the risk of development of the chronic heart failure (CHF) and of atrial fibrillation, and increases functional abilities of the patient. On the other hand, critical increase in the atrioventricular delay leads to pacemaker syndrome: impairment of circulation function, shortness of breath, reduced tolerance to exercise, dizziness, syncopal state. The question of the influence of the permanent electrical pacing on the AV node conduction remains unsolved. AIM: To study the effect of trimetazidine dihydrochloride on the AV node conduction in conditions of permanent cardiac pacing, to determine the effect of cardiac pacing on the AV node in the studied time period. MATERIALS AND METHODS: The study involved 86 patients. The AV node activity was assessed by antegrade intraoperative determination of Wenckebach point on the basis of electrocardiography data in 2448 hours after pacemaker implantation, in 68 hours, 7, 14, 9 and 180 days after intake of trimetazidine dihydrochloride and in 7, 14, 21 and 30 days after its cancellation. To compare the extent of influence of the studied drug on the AV node activity, the patients were divided to three groups depending on the basic pathology: group 1 ― patients with the sick sinus node syndrome (n = 38, 44.2%); group 2 ― patients with II degree AV block (n = 25, 29.1%); group 3 ― patients with III degree AV block (n = 23, 26.7%). RESULTS: Trimetazidine dihydrochloride improved the electrophysiological properties of the AV node in the first and second groups: increase in the mean value of Wenckebach point antegrade in the first group was in total 3.26% (р = 0.022), in the second group 4.68% (р = 0.001). In the third group of patients no improvement was noted, but it should be said that under the action of this drug, in 4 of 23 patients with III degree AV block, antegrade AV conduction appeared (р = 0.236). CONCLUSION: Trimetazidine dihydrochloride has a positive effect on the AV node activity as early as in 68 hours of intake, which reaches maximum in 3 weeks. Cardiac pacing had no effect on AV node within the follow-up period (6 months).
- 7 October 2022
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 30 (3) , 305-312
Study of Electrophysiological Properties of Atrioventricular Node in Permanent Cardiac Pacing under Influence of Trimetazidine Dihydrochloride
INTRODUCTION: Dual-chamber cardiac pacing permits to maintain permanent atrial-ventricular synchronization. Physiological sequence of propagation of the impulse from atria to ventricles is provided with an artificial delay analogous to delay of propagation of excitation through the atrioventricular (AV) node of a heathy individual. The delay interval is formed so that to minimize stimulation of the right ventricle. This preserves the left ventricular ejection fraction, reduces the risk of development of the chronic heart failure (CHF) and of atrial fibrillation, and increases functional abilities of the patient. On the other hand, critical increase in the atrioventricular delay leads to pacemaker syndrome: impairment of circulation function, shortness of breath, reduced tolerance to exercise, dizziness, syncopal state. The question of the influence of the permanent electrical pacing on the AV node conduction remains unsolved. AIM: To study the effect of trimetazidine dihydrochloride on the AV node conduction in conditions of permanent cardiac pacing, to determine the effect of cardiac pacing on the AV node in the studied time period. MATERIALS AND METHODS: The study involved 86 patients. The AV node activity was assessed by antegrade intraoperative determination of Wenckebach point on the basis of electrocardiography data in 2448 hours after pacemaker implantation, in 68 hours, 7, 14, 9 and 180 days after intake of trimetazidine dihydrochloride and in 7, 14, 21 and 30 days after its cancellation. To compare the extent of influence of the studied drug on the AV node activity, the patients were divided to three groups depending on the basic pathology: group 1 ― patients with the sick sinus node syndrome (n = 38, 44.2%); group 2 ― patients with II degree AV block (n = 25, 29.1%); group 3 ― patients with III degree AV block (n = 23, 26.7%). RESULTS: Trimetazidine dihydrochloride improved the electrophysiological properties of the AV node in the first and second groups: increase in the mean value of Wenckebach point antegrade in the first group was in total 3.26% (р = 0.022), in the second group 4.68% (р = 0.001). In the third group of patients no improvement was noted, but it should be said that under the action of this drug, in 4 of 23 patients with III degree AV block, antegrade AV conduction appeared (р = 0.236). CONCLUSION: Trimetazidine dihydrochloride has a positive effect on the AV node activity as early as in 68 hours of intake, which reaches maximum in 3 weeks. Cardiac pacing had no effect on AV node within the follow-up period (6 months).
- Open Access
- 1 September 2021
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 28 (2) , 44-49
Unexpected effects of new COVID-19 infection in arrhythmia surgery
Непредсказуемые эффекты новой инфекции COVID-19 при хирургии аритмий
- 1 September 2021
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 28 (2) , 44-49
Open AccessUnexpected effects of new COVID-19 infection in arrhythmia surgery
Непредсказуемые эффекты новой инфекции COVID-19 при хирургии аритмий